CALIX LIMITED — Director's Dealing 2019

Oct 16, 2019

==> picture [94 x 41] intentionally omitted <==

ASX Announcement

October 17, 2019

Change of Director’s Interest – Appendix 3Y

Sydney, Australia | October 11, 2019 – Multi-award-winning Australian technology company Calix Limited (ASX:CXL) advises that Founder, Chief Scientist and Executive Director, Dr Mark Sceats has exercised $231,000 of unlisted warrants. The warrants have been converted into fully paid shares that are subject to escrow until July 2020.

Appendix 3Y is attached.

==> picture [612 x 60] intentionally omitted <==

==> picture [94 x 41] intentionally omitted <==

For more information:

Darren Charles

Phil Hodgson Managing Director and CEO phodgson@calix.com.au +61 2 8199 7400

Company Secretary and CFO

dcharles@calix.com.au +61 2 8199 7400

Simon Hinsley Investor Relations simon@nwrcommunications.com.au +61 401 809 653

Michelle Taylor Media

Michelle_Taylor@recognition.com.au +61 2 9252 2266

About Calix

Calix is a team of dedicated people developing a unique, patented technology to provide industrial solutions that address global sustainability challenges.

The core technology is being used to develop more environmentally friendly solutions for advanced batteries, crop protection, aquaculture, wastewater, and carbon reduction.

Calix develops its technology via a global network of research and development collaborations, including governments, research institutes and universities, some of world’s largest companies, and a growing customer base and distributor network for its commercialised products and processes.

Because there’s only one Earth – Mars is for Quitters.

==> picture [612 x 60] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity – Calix Limited ABN – 36 117 372 540

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr. Mark Geoffrey Sceats
Date of last notice	9 April 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	-
Date of change	16/10/2019
No. of securities held prior to change Direct Mark Geoffrey Sceats Indirect Mark Geoffrey Sceats Fund> (Trustee & beneficiary) Elizabeth Elenius (Spouse) Adam Vincent & Sina Kassra Scheme A/C> (Beneficiary)	2,965,050 Ordinary shares 766,357 Performance rights 2,759,736 Ordinary shares 412,500 Unlisted Warrants 305,466 Ordinary shares 49,500 Unlisted Warrants 1,312,196 Ordinary shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Fully Paid Ordinary Shares escrowed until July 2020.
Number acquired	462,000
Number disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$231,000
No. of securities held after change Mark Geoffrey Sceats Fund> (Trustee & beneficiary) Elizabeth Elenius (Spouse) Adam Vincent & Sina Kassra Scheme A/C> (Beneficiary) Mark Geoffrey Sceats	3,172,236 Ordinary shares [includes 2,421,052 escrowed until July 2020] 354,966 Ordinary shares [includes 261,050 escrowed until July 2020] 1,312,196 Ordinary shares 2,965,050 Ordinary shares [includes 2,322,126 escrowed until July 2020] 766,357 Performance rights
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Exercise of escrowed warrants expiring on 31 October 2019 in to fully paid ordinary shares escrowed until July 2020

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder (if issued securities)	-
Date of change	-
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	-

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	-
Interest disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	-
Interest after change	-

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	-
If so, was prior written clearance provided to allow the trade to proceed during this period?	-
If prior written clearance was provided, on what date was this provided?	-

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3